BACKED RIGAKU SETS IPO AT1,260 YEN PER SHARE VS 1230-1260 YEN RANGE, REGULATORY FILING SHOWS
TOKYO, Oct 17 (Reuters) -Japanese X-ray testing tool maker Rigaku Holdings 268A.T priced its initial public offering at 1,260 yen per share, at the top end of a 1,230 to 1,260 yen range, a regulatory filing showed on Thursday.
That would put Rigaku, backed by buyout firm Carlyle Group CG.O, on track to raise 129 billion yen ($862.88 million),including an overallotment.
The company will list its shares on the Tokyo Stock Exchange on Oct. 25.
Rigaku's pricing follows that of Tokyo Metro earlier this week. The subway operator priced its shares at the top of its indicative range to raise 348.6 billion yen in Japan's largest IPO in six years.
($1 = 149.5000 yen)
Reporting by Mariko Katsumura; Editing by Christopher Cushing
Latest News
Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.
All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.
Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.
